Epigenetic tools (The Writers, The Readers and The Erasers) and their implications in cancer therapy.

Addition of chemical tags on the DNA and modification of histone proteins impart a distinct feature on chromatin architecture. With the advancement in scientific research, the key players underlying these changes have been identified as epigenetic modifiers of the chromatin. Indeed, the plethora of enzymes catalyzing these modifications, portray the diversity of epigenetic space and the intricacy in regulating gene expression. These epigenetic players are categorized as writers: that introduce various chemical modifications on DNA and histones, readers: the specialized domain containing proteins that identify and interpret those modifications and erasers: the dedicated group of enzymes proficient in removing these chemical tags. Research over the past few decades has established that these epigenetic tools are associated with numerous disease conditions especially cancer. Besides, with the involvement of epigenetics in cancer, these enzymes and protein domains provide new targets for cancer drug development. This is certain from the volume of epigenetic research conducted in universities and R&D sector of pharmaceutical industry. Here we have highlighted the different types of epigenetic enzymes and protein domains with an emphasis on methylation and acetylation. This review also deals with the recent developments in small molecule inhibitors as potential anti-cancer drugs targeting the epigenetic space.

• Publication year

  2018

• Venue

  European Journal of Pharmacology

• Publication date

  2018-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2018.08.021PMID 30125562
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TP-064, a potent and selective small molecule inhibitor of PRMT4 for multiple myeloma

  2018cited by this paper
• KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin‐1‐mediated chromatin silencing

  2018cited by this paper
• Crystal structure of chromo barrel domain of RBBP1

  2018cited by this paper
• LLY-283, a Potent and Selective Inhibitor of Arginine Methyltransferase 5, PRMT5, with Antitumor Activity.

  2018cited by this paper
• Identification of a peptide inhibitor for the histone methyltransferase WHSC1

  2018cited by this paper
• Reversible LSD1 inhibition with HCI-2509 induces the p53 gene expression signature and disrupts the MYCN signature in high-risk neuroblastoma cells

  2018cited by this paper
• Lysine methyltransferase SMYD2 promotes cyst growth in autosomal dominant polycystic kidney disease

  2017cited by this paper
• WD40 repeat domain proteins: a novel target class?

  2017cited by this paper
• YEATS Domain-A Histone Acylation Reader in Health and Disease.

  2017cited by this paper
• Exploitation of EP300 and CREBBP Lysine Acetyltransferases by Cancer.

  2017cited by this paper
• The EED protein-protein interaction inhibitor A-395 inactivates the PRC2 complex.

  2017cited by this paper
• The DNA methyltransferase family: a versatile toolkit for epigenetic regulation

  2017cited by this paper
• Epigenetics in cancer: Fundamentals and Beyond.

  2017cited by this paper
• An allosteric PRC2 inhibitor targeting the H3K27me3 binding pocket of EED.

  2017cited by this paper
• Histone acetyltransferase p300/CBP inhibitor C646 blocks the survival and invasion pathways of gastric cancer cell lines.

  2017cited by this paper
• Inhibitors of Protein Methyltransferases and Demethylases

  2017cited by this paper
• Writing, erasing and reading histone lysine methylations

  2017cited by this paper
• Identification of a CARM1 Inhibitor with Potent In Vitro and In Vivo Activity in Preclinical Models of Multiple Myeloma

  2017cited by this paper
• Jmjd6, a JmjC Dioxygenase with Many Interaction Partners and Pleiotropic Functions

  2017cited by this paper
• Sirtuin Inhibition: Strategies, Inhibitors, and Therapeutic Potential.

  2017cited by this paper
• Readers of DNA methylation, the MBD family as potential therapeutic targets.

  2017cited by this paper
• Downregulation of PARP1 transcription by promoter-associated E2F4-RBL2-HDAC1-BRM complex contributes to repression of pluripotency stem cell factors in human monocytes

  2017cited by this paper
• LSD1: biologic roles and therapeutic targeting

  2016cited by this paper
• Recent Progress in Histone Demethylase Inhibitors.

  2016cited by this paper
• Reduction in promotor methylation utilizing EGCG (epigallocatechin-3-gallate) restores RXRα expression in human colon cancer cells

  2016cited by this paper
• Chemical Inhibitors of Epigenetic Methyllysine Reader Proteins.

  2016cited by this paper
• Discovery of I-BRD9, a Selective Cell Active Chemical Probe for Bromodomain Containing Protein 9 Inhibition.

  2016cited by this paper
• The TIP60 Complex Regulates Bivalent Chromatin Recognition by 53BP1 through Direct H4K20me Binding and H2AK15 Acetylation.

  2016cited by this paper
• The RNA methyltransferase Dnmt2 methylates DNA in the structural context of a tRNA

  2016cited by this paper
• Discovery of a Potent, Selective, and Cell-Active Dual Inhibitor of Protein Arginine Methyltransferase 4 and Protein Arginine Methyltransferase 6.

  2016cited by this paper
• G9a inhibition potentiates the anti-tumour activity of DNA double-strand break inducing agents by impairing DNA repair independent of p53 status

  2016cited by this paper
• Metabolic regulation of gene expression through histone acylations

  2016cited by this paper
• The BAH domain of BAHD1 is a histone H3K27me3 reader

  2016cited by this paper
• Structure-Based Design of an in Vivo Active Selective BRD9 Inhibitor

  2016cited by this paper
• A Potent, Selective, and Cell-Active Inhibitor of Human Type I Protein Arginine Methyltransferases.

  2016cited by this paper
• OTX015 (MK‐8628), a novel BET inhibitor, displays in vitro and in vivo antitumor effects alone and in combination with conventional therapies in glioblastoma models

  2016cited by this paper
• Bromodomain inhibitors and cancer therapy: From structures to applications

  2016cited by this paper
• The Importance of Being Me: Magic Methyls, Methyltransferase Inhibitors, and the Discovery of Tazemetostat.

  2016cited by this paper
• BRD4 is a Histone Acetyltransferase that Evicts Nucleosomes from Chromatin

  2016cited by this paper
• Protein arginine methyltransferase 10 is required for androgen-dependent proliferation of LNCaP prostate cancer cells

  2015cited by this paper
• DNA methylation requires a DNMT1 ubiquitin interacting motif (UIM) and histone ubiquitination

  2015cited by this paper
• Histone demethylases in chromatin biology and beyond

  2015cited by this paper
• Aryl Pyrazoles as Potent Inhibitors of Arginine Methyltransferases: Identification of the First PRMT6 Tool Compound.

  2015cited by this paper
• Discovery of A-893, A New Cell-Active Benzoxazinone Inhibitor of Lysine Methyltransferase SMYD2.

  2015cited by this paper
• LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2

  2015cited by this paper
• PRMT9 is a Type II methyltransferase that methylates the splicing factor SAP145

  2015cited by this paper
• Targeting DNA Methylation with Green Tea Catechins

  2015cited by this paper
• Final Results from a Phase 2 Study of Pracinostat in Combination with Azacitidine in Elderly Patients with Acute Myeloid Leukemia (AML)

  2015cited by this paper
• Panobinostat for the treatment of multiple myeloma

  2015cited by this paper
• A potent, selective and cell-active allosteric inhibitor of protein arginine methyltransferase 3 (PRMT3).

  2015cited by this paper
• A selective inhibitor of PRMT5 with in vivo and in vitro potency in MCL models.

  2015cited by this paper
• Protein Lysine Acetylation by p300/CBP

  2015cited by this paper
• Methyl-CpG-binding domain proteins: readers of the epigenome.

  2015cited by this paper
• MOZ and MORF acetyltransferases: Molecular interaction, animal development and human disease.

  2015cited by this paper
• Small-molecule modulators of methyl-lysine binding for the CBX7 chromodomain.

  2015cited by this paper
• The Histone Methyltransferase Inhibitor A-366 Uncovers a Role for G9a/GLP in the Epigenetics of Leukemia

  2015cited by this paper
• Panobinostat for the Treatment of Multiple Myeloma

  2015cited by this paper
• Histone acetyltransferase inhibitors block neuroblastoma cell growth in vivo

  2015cited by this paper
• The SUV39H1 inhibitor chaetocin induces differentiation and shows synergistic cytotoxicity with other epigenetic drugs in acute myeloid leukemia cells

  2015cited by this paper
• Human UTY(KDM6C) Is a Male-specific Nϵ-Methyl Lysyl Demethylase

  2014cited by this paper
• A Selective Phenelzine Analogue Inhibitor of Histone Demethylase LSD1

  2014cited by this paper
• MBD2 and MBD3: elusive functions and mechanisms

  2014cited by this paper
• Competitive Binding of a Benzimidazole to the Histone-Binding Pocket of the Pygo PHD Finger

  2014cited by this paper
• The Ten-Eleven Translocation-2 (TET2) gene in hematopoiesis and hematopoietic diseases

  2014cited by this paper
• Diamidine Compounds for Selective Inhibition of Protein Arginine Methyltransferase 1

  2014cited by this paper
• Targeting histone lysine demethylases — Progress, challenges, and the future

  2014cited by this paper
• Rational design and validation of a Tip60 histone acetyltransferase inhibitor

  2014cited by this paper
• Belinostat for the treatment of peripheral T-cell lymphomas.

  2014cited by this paper
• Targeting MLL1 H3K4 methyltransferase activity in mixed-lineage leukemia.

  2014cited by this paper
• Discovery and Optimization of Small-Molecule Ligands for the CBP/p300 Bromodomains

  2014cited by this paper
• MBD4 cooperates with DNMT1 to mediate methyl-DNA repression and protects mammalian cells from oxidative stress

  2014cited by this paper
• DOT1L Inhibition Sensitizes MLL-Rearranged AML to Chemotherapy

  2014cited by this paper
• New concepts in DNA methylation.

  2014cited by this paper
• Sirtuin inhibitors as anticancer agents.

  2014cited by this paper
• AF9 YEATS domain links histone acetylation to DOT1L-mediated H3K79 methylation.

  2014cited by this paper
• A Comprehensive View of the Epigenetic Landscape Part I: DNA Methylation, Passive and Active DNA Demethylation Pathways and Histone Variants

  2014cited by this paper
• An orally bioavailable chemical probe of the Lysine Methyltransferases EZH2 and EZH1.

  2013cited by this paper
• Histone acetyltransferase 1: more than just an enzyme?

  2013cited by this paper
• Histone H4 Lysine 20 methylation: key player in epigenetic regulation of genomic integrity

  2013cited by this paper
• Gossypol and an HMT G9a inhibitor act in synergy to induce cell death in pancreatic cancer cells

  2013cited by this paper
• ZF-CxxC domain-containing proteins, CpG islands and the chromatin connection

  2013cited by this paper
• Potent inhibition of DOT1L as treatment of MLL-fusion leukemia.

  2013cited by this paper
• Automethylation of Protein Arginine Methyltransferase 8 (PRMT8) Regulates Activity by Impeding S-Adenosylmethionine Sensitivity*

  2013cited by this paper
• Nahuoic acid A produced by a Streptomyces sp. isolated from a marine sediment is a selective SAM-competitive inhibitor of the histone methyltransferase SETD8.

  2013cited by this paper
• DNA Methylation and Its Basic Function

  2013cited by this paper
• Histone H3 lysine 4 methyltransferases and demethylases in self-renewal and differentiation of stem cells

  2013cited by this paper
• Role of Tet1 in erasure of genomic imprinting

  2013cited by this paper
• Concise drug review: azacitidine and decitabine.

  2013cited by this paper
• Nicotinamide-mediated inhibition of SIRT1 deacetylase is associated with the viability of cancer cells exposed to antitumor agents and apoptosis

  2013cited by this paper
• Histone lysine demethylase (KDM) subfamily 4: structures, functions and therapeutic potential.

  2013cited by this paper
• Probing p300/CBP associated factor (PCAF)-dependent pathways with a small molecule inhibitor.

  2013cited by this paper
• DNA Methyltransferases: A Novel Target for Prevention and Therapy

  2013cited by this paper
• 5-Carboxy-8-hydroxyquinoline is a Broad Spectrum 2-Oxoglutarate Oxygenase Inhibitor which Causes Iron Translocation.

  2013cited by this paper
• ZBTB33 binds unmethylated regions of the genome associated with actively expressed genes

  2013cited by this paper
• Identification and characterization of small molecule inhibitors of a plant homeodomain finger.

  2012cited by this paper
• Histone Recognition and Large-Scale Structural Analysis of the Human Bromodomain Family

  2012cited by this paper
• Histone H3R17me2a mark recruits human RNA Polymerase-Associated Factor 1 Complex to activate transcription

  2012cited by this paper
• 6-alkylsalicylates are selective Tip60 inhibitors and target the acetyl-CoA binding site.

  2012cited by this paper
• SIRT4 coordinates the balance between lipid synthesis and catabolism by repressing malonyl CoA decarboxylase.

  2012cited by this paper
• Human Protein Arginine Methyltransferase 7 (PRMT7) Is a Type III Enzyme Forming ω-NG-Monomethylated Arginine Residues*

  2012cited by this paper

• Mechanisms of DNA methyltransferase 3A1 mediated DNA methylation of nucleosomes.

  2026cites this paper
• A Comprehensive Guide on Epigenetics' Precision Role in Uncommon "Rare" Cancers' Biology and Treatment Frontiers.

  2026cites this paper
• The Epigenetic Angle in the Precision Medicine Era for Blood Disorder Advancements.

  2026cites this paper
• Investigating the epigenetic modulating potential of gallic acid during ethanol-induced toxicity: In silico and in vitro approaches.

  2026cites this paper
• Influence of the Electrostatic Tuning of Alkyl and Benzyl Groups on Cation-π Interactions in Histone Reader Proteins and β-Hairpin Peptides.

  2026cites this paper
• Targeting Lactate and Lactylation in Cancer Metabolism and Immunotherapy.

  2026cites this paper
• DNA methyltransferase inhibitors in oncology: clinical progress, limitations and future directions.

  2026cites this paper
• The Epigenetic Battleground: Host Chromatin at the Core of Infection.

  2026cites this paper
• Lytic or Latent Phase in Human Cytomegalovirus Infection: An Epigenetic Trigger

  2025cites this paper
• Intelligence of Matter: Rise of a New Style of Doing Science and Scientific Thinking?

  2025cites this paper
• Epigenetic editing and epi-drugs: a combination strategy to simultaneously target KDM4 as a novel anticancer approach

  2025cites this paper
• Pharmacology of Epitranscriptomic Modifications: Decoding the Therapeutic Potential of RNA Modifications in Drug Resistance.

  2025cites this paper
• A Comprehensive Review of Current Approaches in Bladder Cancer Treatment.

  2025cites this paper
• From Metabolic to Epigenetic Memory: The Impact of Hyperglycemia-Induced Epigenetic Signature on Kidney Disease Progression and Complications

  2025cites this paper
• Predictors of Radiation Resistance and Novel Radiation Sensitizers in Head and Neck Cancers: Advancing Radiotherapy Efficacy.

  2025cites this paper
• Proteomics-Based Trapping to Study Substrates of Histone Deacetylase 6 Catalytic Domain 1.

  2025cites this paper
• Multiple Epigenetic Mechanisms Functionally Cooperate to Silence Expression of Somatostatin Receptor Type 2 in Pancreatic Neuroendocrine Tumors

  2025cites this paper
• Multi-omics based and AI-driven drug repositioning for epigenetic therapy in female malignancies

  2025cites this paper
• Epitranscriptomics Regulation of CD70, CD80, and TIGIT in Cancer Immunity

  2025cites this paper
• Lactate Dehydrogenase C4 Accelerates Triple‐Negative Breast Cancer Progression by Promoting Acetyl‐CoA Acyltransferase 2 Lactylation to Increase Free Fatty Acid Accumulation

  2025cites this paper
• Acetylation-Mediated Epigenetic Consequences for Biological Control and Cancer.

  2025cites this paper
• Lactate and lactylation: emerging roles in autoimmune diseases and metabolic reprogramming

  2025cites this paper
• Integration of epigenetics into ecotoxicology: insights and fundamental research needs

  2025cites this paper
• Epigenomic profiling of papillary thyroid carcinoma reveals distinct subtypes with clinical implications

  2025cites this paper
• Allosteric Inhibitors of Cell-Cycle-Regulated Methyltransferase for Novel Antibiotic Development

  2025cites this paper
• Impact of Tyrosine Kinase Inhibitors on the Expression Pattern of Epigenetic Regulators

  2025cites this paper
• Scaffolding Activities of Pseudodeacetylase HDAC7.

  2025cites this paper
• Protein succinylation mechanisms and potential targeted therapies in urinary disease.

  2025cites this paper
• Anticancer benzimidazole derivatives as inhibitors of epigenetic targets: a review article

  2025cites this paper
• The Evolutionary Reasons of Epigenetics

  2025cites this paper
• Histone Deacetylase Inhibitors orchestrate epigenetic signalling and alter the nucleoporins and nuclear envelope in cervical cancer

  2025cites this paper
• Pancreas meets brain: β-hydroxybutyrate as a novel "β-cellular" metabolism therapy.

  2025cites this paper
• The epigenetic landscape of rheumatoid arthritis: Pathogenesis and drug therapeutic potentials

  2025cites this paper
• Epigenetic mechanisms in HCC immune landscape: Therapeutic implications.

  2025cites this paper
• HOXA10 and HOXA11 Methylation: Epigenetic Barriers to Endometrial Receptivity in ART

  2025cites this paper
• Exploring the uncharted role of cell senescence in rare diseases

  2025cites this paper
• BRD9 functions as a methylarginine reader to regulate AKT-EZH2 signaling

  2025cites this paper
• Unraveling the interplay of genetic variants and epigenetic signatures in complex traits.

  2025cites this paper
• Histone H3 N-terminal recognition by the PHD finger of PHRF1 is required for proper DNA damage response

  2025cites this paper
• Expression landscape of epigenetic genes in human hepatocellular carcinoma

  2025cites this paper
• Phylogenomic analysis of bromodomain genes in cotton (Gossypium spp.) and their potential roles in abiotic stress tolerance

  2025cites this paper
• CRISPR/Cas9 genome engineering in PDAC: from preclinical studies to translation and clinical research.

  2025cites this paper
• How histone modifications influence cellular radiosensitivity: Pharmaceutically targeting epigenetic regulators as a promising avenue to overcome radioresistance

  2025cites this paper
• LncRNAs signatures in gynecological cancers: ovarian and endometrial cancers

  2025cites this paper
• Targeted Histone Deacetylase Degradation via Chemical Induced Proximity by Direct Recruitment of the CUL4 Complex Adaptor Protein DDB1.

  2025cites this paper
• Epigenetic Regulation in the Pathogenesis of Periodontitis.

  2025cites this paper
• Role of human Myocyte Enhancer Factor 2 (MEF2) proteins in cancer: structural insights, functional diversity, and regulatory mechanisms

  2025cites this paper
• The Articular Chromatin Landscape in Osteoarthritis

  2025cites this paper
• Engineering unnatural cells with a 21st amino acid as a living epigenetic sensor

  2025cites this paper
• Transcriptomic profiling of epigenetic regulators and metabolic reprogramming in human cholangiocarcinoma

  2025cites this paper
• Physical models reveal indirect reader protein interactions that facilitate epigenetic crosstalk.

  2025cites this paper
• Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.

  2025cites this paper
• Management of T‐cell malignancies: Bench‐to‐bedside targeting of epigenetic biology

  2025cites this paper
• P300 regulates Melanophilin expression by modulating TFAP2A binding through histone acetylation.

  2025cites this paper
• Epigenetic targeting in oral squamous cell carcinoma: mechanisms, therapies, and translational potential

  2025cites this paper
• Methylation pseudotime analysis for label-free profiling of the temporal chromatin landscape with long-read sequencing

  2025cites this paper
• Overview of the epigenetic/cytotoxic dual-target inhibitors for cancer therapy.

  2025cites this paper
• Nucleosome context regulates chromatin reader preference

  2025cites this paper
• Epigenetic Regulatory Processes Involved in the Establishment and Maintenance of Skin Homeostasis—The Role of Microbiota

  2025cites this paper
• Investigating the origins of the mutational signatures in cancer

  2025cites this paper
• Epigenetic Mechanisms Underlying Sex Differences in Neurodegenerative Diseases

  2025cites this paper
• Epigenetic Control of Redox Pathways in Cancer Progression

  2025cites this paper
• Advances in epigenetic treatment of adult T-cell leukemia/lymphoma: a comprehensive review

  2025cites this paper
• Research progress on the mechanism of tumor cell ferroptosis regulation by epigenetics

  2025cites this paper
• Epigenetic Therapeutics in Human Heart Failure.

  2025cites this paper
• PHF20L1: An Epigenetic Regulator in Cancer and Beyond

  2025cites this paper
• Aberrant histone modifications in pediatric brain tumors

  2025cites this paper
• Development of a High-Throughput Platform for Quantitation of Histone Modifications on a New QTOF Instrument

  2024cites this paper
• Lactylation Modification in Cardio-cerebral Diseases: A State-of-the-art Review.

  2024cites this paper
• Histone H3 N-terminal recognition by the PHD finger of PHRF1 is required for proper DNA damage response

  2024cites this paper
• Resolution of Chronic Inflammation, Restoration of Epigenetic Disturbances and Correction of Dysbiosis as an Adjunctive Approach to the Treatment of Atopic Dermatitis

  2024cites this paper
• Epigenetic Landscape of DNA Methylation in Pancreatic Ductal Adenocarcinoma

  2024cites this paper
• The role of epigenetic methylations in thyroid Cancer

  2024cites this paper
• Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery

  2024cites this paper
• Covalent inhibitors meet epigenetics: New opportunities.

  2024cites this paper
• LncRNAs and the Cancer Epigenome: Mechanisms and Therapeutic Potential.

  2024cites this paper
• The impact of sex on memory during aging and Alzheimer's disease progression: Epigenetic mechanisms

  2024cites this paper
• The Role of DNMT Methyltransferases and TET Dioxygenases in the Maintenance of the DNA Methylation Level

  2024cites this paper
• Epigenetic-modifying agents: the potential game changers in the treatment of hematologic malignancies.

  2024cites this paper
• Histone Modifications in the Anoxic Northern Crayfish, Faxonius virilis

  2024cites this paper
• Glyphosate and a glyphosate-based herbicide dysregulate the epigenetic landscape of Homeobox A10 (Hoxa10) gene during the endometrial receptivity in Wistar rats

  2024cites this paper
• Uterine fibroids: current research on novel drug targets and innovative therapeutic strategies

  2024cites this paper
• Linker and tail group modifications on 2-((4-isopropyl-4H-1,2,4-triazol-3-yl)thio)-N-(4-phenoxyphenyl)acetamide to improve SIRT2 inhibitory potency

  2024cites this paper
• Epigenetic modulation of immune cells: Mechanisms and implications.

  2024cites this paper
• Overview of class I HDAC modulators: Inhibitors and degraders.

  2024cites this paper
• Diabetes and Early Development: Epigenetics, Biological Stress, and Aging

  2024cites this paper
• Small molecules targeting HDAC6 for cancer treatment: Current progress and novel strategies.

  2024cites this paper
• Food Chemicals and Epigenetic Targets: An Epi Food Chemical Database

  2024cites this paper
• Bioorthogonal Labeling and Enrichment of Histone Monoaminylation Reveal Its Accumulation and Regulatory Function in Cancer Cell Chromatin.

  2024cites this paper
• DNA Tandem Repeats as Iterable Objects to Count Cell Divisions: A Computational Model

  2024cites this paper
• Endocrine features of Prader-Willi syndrome: a narrative review focusing on genotype-phenotype correlation

  2024cites this paper
• Short- and Long-Term Effects of Subchronic Stress Exposure in Male and Female Brain-Derived Neurotrophic Factor Knock-In Val66Met Mice

  2024cites this paper
• Structural Investigations of Phthalazinone Derivatives as Allosteric Inhibitors of Human DNA Methyltransferase 3A

  2024cites this paper
• Physical modeling of nucleosome clustering in euchromatin resulting from interactions between epigenetic reader proteins

  2024cites this paper
• A review of the role of epigenetic studies for intramuscular fat deposition in beef cattle.

  2024cites this paper
• Epigenetics as a determinant of radiation response in cancer.

  2024cites this paper
• Targeting bromodomian-containing protein 8 (BRD8): An advanced tool to interrogate BRD8.

  2024cites this paper
• Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer

  2024cites this paper
• Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures

  2024cites this paper
• Regulation of newly identified lysine lactylation in cancer.

  2024cites this paper